Serveur d'exploration COVID et hydrochloroquine - Corpus (Accueil)

Index « MedMesh.i » - entrée « Drug Interactions »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Drug Information Services < Drug Interactions < Drug Monitoring  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 43.
[0-20] [0 - 20][0 - 43][20-40]
Ident.Authors (with country if any)Title
000187 (2021) Byung Jin Choi ; Yeryung Koo ; Tae Young Kim ; Wou Young Chung ; Yun Jung Jung ; Ji Eun Park ; Hong-Seok Lim ; Bumhee Park ; Dukyong YoonRisk of QT prolongation through drug interactions between hydroxychloroquine and concomitant drugs prescribed in real world practice.
000227 (2021) Guillaume Hache ; Jean Marc Rolain ; Philippe Gautret ; Jean-Claude Deharo ; Philippe Brouqui ; Didier Raoult ; Stéphane HonoréCombination of Hydroxychloroquine Plus Azithromycin As Potential Treatment for COVID-19 Patients: Safety Profile, Drug Interactions, and Management of Toxicity.
000487 (2020) Remdesivir (Veklury) for COVID-19.
000523 (2021) Beatriz Oda Plasencia-García ; Gonzalo Rodríguez-Menéndez ; María Isabel Rico-Rangel ; Ana Rubio-García ; Jaime Torell Iserte ; Benedicto Crespo-FacorroDrug-drug interactions between COVID-19 treatments and antipsychotics drugs: integrated evidence from 4 databases and a systematic review.
000527 (2021) Philippe Gautret ; Jean-Christophe Lagier ; Stéphane Honoré ; Van Thuan Hoang ; Didier RaoultClinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19.
000534 (2021) Philippe Gautret ; Stéphane Honoré ; Jean-Christophe Lagier ; Didier RaoultSafety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients.
000544 (2021) Philippe Gautret ; Jean-Christophe Lagier ; Stéphane Honoré ; Van Thuan Hoang ; Philippe Colson ; Didier RaoultHydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited.
000686 (2020) Hilary Miller-Handley ; Keith Luckett ; Amit GovilTreatment Options for Coronavirus Disease 2019 in Patients With Reduced or Absent Kidney Function.
000707 (2020) Slobodan Rendic ; Frederick Peter GuengerichMetabolism and Interactions of Chloroquine and Hydroxychloroquine with Human Cytochrome P450 Enzymes and Drug Transporters.
000745 (2021) Gayathri Baburaj ; Levin Thomas ; Mahadev RaoPotential Drug Interactions of Repurposed COVID-19 Drugs with Lung Cancer Pharmacotherapies.
000748 (2020) Tarek Kashour ; Imad M. TleyjehIt is time to drop hydroxychloroquine from our COVID-19 armamentarium.
000891 (2020) Dario Cattaneo ; Luca Pasina ; Aldo Pietro Maggioni ; Andrea Giacomelli ; Letizia Oreni ; Alice Covizzi ; Lucia Bradanini ; Marco Schiuma ; Spinello Antinori ; Annalisa Ridolfo ; Cristina GervasoniDrug-Drug Interactions and Prescription Appropriateness in Patients with COVID-19: A Retrospective Analysis from a Reference Hospital in Northern Italy.
000914 (2021) Cosmin Andrei Cismaru ; Gabriel Laurentiu Cismaru ; Fazel Seyed Nabavi ; Mohammad Seyed Nabavi ; Ioana Berindan-NeagoeCOVID-19 and antimalarials. Have we been doing it wrong all along?
000965 (2021) Berta Saez-Giménez ; Cristina Berastegui ; Miriam Barrecheguren ; Eva Revilla-L Pez ; Ibai Los Arcos ; Rodrigo Alonso ; Myriam Aguilar ; Víctor M. Mora ; Isabel Otero ; Juan P. Reig ; Carlos A. Quezada ; Virginia Pérez ; Manuel Valle ; Rosalía Laporta ; María Deu ; Judith Sacanell ; Carles Bravo ; Joan Gavalda ; Manuel Lopez-Meseguer ; Víctor MonforteCOVID-19 in lung transplant recipients: A multicenter study.
000B85 (2020) Naeem A. Alshoaibi ; Khadijah Maghrabi ; Haitham Alanazi ; Mousa Al Harbi ; Saleh AlghamdiSaudi Heart Rhythm Society Task Force on Management of Potential Arrhythmogenicity Associated with Pharmacotherapy for COVID-19.
000C31 (2020) Peng Liu ; Liwei Zhao ; Gladys Ferrere ; Carolina Alves-Costa-Silva ; Pierre Ly ; Qi Wu ; Ai-Ling Tian ; Lisa Derosa ; Laurence Zitvogel ; Oliver Kepp ; Guido KroemerCombination treatments with hydroxychloroquine and azithromycin are compatible with the therapeutic induction of anticancer immune responses.
000D22 (2020) Seema Rani ; Sandeep Grover ; Aseem Mehra ; Swapnajeet SahooPsychiatric implications of the use of hydroxychloroquine in COVID-19 patients.
000E36 (2020) Elton Dajti ; Francesco Cristini ; Giacomo Tamanini ; Matteo Cescon ; Franco Bazzoli ; Mariarosa TamèCOVID-19 in a young liver transplant recipient: caution for drug-drug interactions.
000E48 (2021) Carlotta Sciaccaluga ; Matteo Cameli ; Daniele Menci ; Giulia Elena Mandoli ; Nicol Sisti ; Paolo Cameli ; Federico Franchi ; Sergio Mondillo ; Serafina ValenteCOVID-19 and the burning issue of drug interaction: never forget the ECG.
000E84 (2020) Brandon S. Hamm ; Lisa J. RosenthalPsychiatric Aspects of Chloroquine and Hydroxychloroquine Treatment in the Wake of Coronavirus Disease-2019: Psychopharmacological Interactions and Neuropsychiatric Sequelae.
000F40 (2020) Lauren A. Schluenz ; Gerardo P. Ramos-Otero ; James J. NawarskasChloroquine or Hydroxychloroquine for Management of Coronavirus Disease 2019: Friend or Foe?

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/MedMesh.i -k "Drug Interactions" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/MedMesh.i  \
                -Sk "Drug Interactions" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Drug Interactions
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021